Research: Cannabis Use Doesn't Hinder Quitting Nicotine Vaping
Summary
Researchers from Mass General Brigham conducted a clinical trial with 261 participants aged 16-25 to investigate the impact of cannabis use on nicotine vaping cessation. The study found that varenicline, a medication aiding nicotine cessation, was effective regardless of the participants’ cannabis use. Approximately 28% of participants reported no cannabis use, 38% used it one-to-three days a week, and 30% used it four-to-seven days a week. Contrary to initial hypotheses, cannabis use did not hinder the ability to quit vaping, and varenicline consistently showed higher abstinence rates compared to behavioral support alone. The medication also did not affect cannabis usage rates. The findings suggest that cannabis use shouldn't be considered a barrier to vaping cessation treatment and can inform public health messaging and treatment planning.
(Source:Mirage News)